Show simple item record

dc.contributor.authorAmelia, Amelia
dc.contributor.authorRonald, Ronald
dc.date.accessioned2019-07-10T10:27:03Z
dc.date.available2019-07-10T10:27:03Z
dc.date.issued2016-09-24
dc.identifier.issn1752-0479
dc.identifier.urihttp://hdl.handle.net/123456789/1380
dc.description.abstractSince 2014, Indonesia began imposing the National Health Insurance program. One of the goals of implementing the program is to increase the use of generic drugs. This action was done to respond the low use of generic drugs, which is around 11%, in 2011 (World Bank, 2008). Therefore, this study tried to examine the factors that influence the purchase intention of generic drugs based on the information from physicians and pharmacists. Also the overall information risk with experience was used as moderating variable. The research sample for this includes 400 respondents. The questionnaires were distributed from September 2014 until December 2015. The questionnaire distribution takes a relatively long time due to the very small number of generic drug users were available. The result shows that physician information have the biggest effect on the purchase intention of generic drugs, and that experience has a significant effect as moderating variableen_US
dc.language.isoenen_US
dc.publisherInderscience Enterprises Ltd.en_US
dc.relation.ispartofseriesVol. 11, No. 3;
dc.subjectGeneric Drugsen_US
dc.subjectPhysician Informationen_US
dc.subjectPharmacist Informationen_US
dc.subjectExperienceen_US
dc.subjectIndonesiaen_US
dc.titleGeneric drug in Indonesia: why physicians and pharmacists mattersen_US
dc.typeJournalen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record